Trulieve Cannabis Corp. (CSE:TRUL)
Canada
· Delayed Price · Currency is CAD | Market Cap | 3.10B |
| Revenue (ttm) | 1.63B |
| Net Income (ttm) | -113.21M |
| Shares Out | 192.31M |
| EPS (ttm) | -0.59 |
| PE Ratio | n/a |
| Forward PE | 63.04 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 890,807 |
| Average Volume | 323,302 |
| Open | 17.90 |
| Previous Close | 18.15 |
| Day's Range | 15.63 - 18.50 |
| 52-Week Range | 4.45 - 18.50 |
| Beta | 1.86 |
| RSI | 63.60 |
| Earnings Date | Aug 7, 2026 |
About Trulieve Cannabis
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsyl... [Read more]
Financial Performance
In 2025, Trulieve Cannabis's revenue was $1.18 billion, a decrease of -0.45% compared to the previous year's $1.19 billion. Losses were -$116.38 million, -24.97% less than in 2024.
Financial numbers in USD Financial StatementsNews
Trulieve Cannabis Proxy statement: Proxy filing
Trulieve Cannabis filed a proxy statement on June 25, 2026, providing details for shareholder voting and corporate governance matters.
Trulieve Cannabis Proxy statement: Proxy filing
Trulieve Cannabis filed a proxy statement on June 25, 2026, providing details for shareholder voting and corporate governance matters.
3 Marijuana Stocks To Watch In 2026 That Could Soon Rise In Trading
With the continued growth and expansion of the cannabis industry, companies are witnessing another shift. Between the USA and Canada, more companies are focused on better branding and marketing attach...
Here Are 3 Marijuana Stocks To Follow For Better Investing
Over the last several weeks, there have been days when marijuana stocks caught a volatile upswing. Even if only for a short moment, there have been more days like this, allowing some investors to see ...
Trulieve Cannabis Corp (TRLV) Shares Fall 10.4% -- GF Value Says Still Overvalued
Trulieve Cannabis Corp (TRLV) Shares Fall 10.4% -- GF Value Says Still Overvalued
Trulieve Cannabis Proxy statement: Proxy filing
Trulieve Cannabis filed a proxy statement on June 12, 2026, providing details for shareholder voting and corporate governance matters.
Trulieve Cannabis Corp Annual Shareholders Meeting Transcript
Trulieve Cannabis Corp Annual Shareholders Meeting Transcript
Trulieve Cannabis management to meet with Needham
Meeting to be held in New York on June 10-11 hosted by Needham.
3 Leading Marijuana Stocks Investors Are Watching in June 2026
The cannabis sector continues evolving as operators focus on profitability, cash flow, and market expansion. Federal cannabis reform discussions remain a major catalyst. Meanwhile, leading multistate ...
Trulieve Announces Share Repurchase Program
TALLAHASSEE, Fla., June 9, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., tod...
Trulieve Cannabis (TCNNF) to Begin Trading on NYSE as TRLV
Trulieve Cannabis (TCNNF) to Begin Trading on NYSE as TRLV
Trulieve Announces Uplist to NYSE
Subordinate Voting Shares expected to begin trading under ticker "TRLV" on Wednesday, June 10 TALLAHASSEE, Fla., June 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Truli...
Trulieve Cannabis Slides: Investor presentation
Trulieve Cannabis has posted slides in relation to its latest quarterly earnings report, which was published on June 5, 2026.
Alliance Global says Trulieve Cannabis positioned well for NYSE listing
Alliance Global analyst Aaron Grey noted Trulieve is in a “unique” position given its weighting current operations being in medical-only states and it has key catalysts in medical-only states given…
Trulieve Cannabis deconsolidates Harvest business to pursue NYSE listing
In a regulatory filing yesterday, Trulieve Cannabis (TCNNF) entered into several agreements to facilitate the deconsolidation of the financial results of its former indirectly wholly-owned subsidiary,...
Best Marijuana Stocks to Watch for Potential Upside in June 2026
As June 2026 begins, cannabis investors continue searching for companies with strong operations and improving profitability. Although the industry still faces regulatory challenges, many leading opera...
3 Marijuana Stocks For Better Investing In 2026
The cannabis industry has evolved into a multi-billion-dollar sector. From the USA, Canada, Europe, and other global regions. This success has opened up a world to investors, from startups to regular ...
3 Marijuana Stocks To Know About Now In 2026
The cannabis industry once again is going through some big changes. Nearly every state in the USA has some form of legal cannabis legislation. Now, with the recent passing of cannabis being considered...
Trulieve Announces Proposed Domestication from British Columbia to Delaware
TALLAHASSEE, Fla., May 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today annou...
Top Marijuana Companies Building Momentum In 2026
The cannabis sector continues attracting investors in May 2026. Federal reform discussions remain a major catalyst for marijuana stocks. Additionally, many traders expect more progress regarding canna...
Trulieve Cannabis price target raised to C$27 from C$19 at Alliance Global
Alliance Global raised the firm’s price target on Trulieve Cannabis (TCNNF) to C$27 from C$19 and keeps a Buy rating on the shares. The firm views the company’s Q1 report…
Trulieve Cannabis Earnings Call Transcript: Q1 2026
Q1 revenue was $287M with a 59% gross margin and $100M adjusted EBITDA, reflecting strong operational performance. Medical marijuana's reclassification to Schedule III removes the 280E tax burden, boosting cash flow and enabling new growth and M&A opportunities.
Trulieve Cannabis Slides: Q1 2026
Trulieve Cannabis has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Trulieve Cannabis Earnings release: Q1 2026
Trulieve Cannabis released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Trulieve Cannabis Quarterly report: Q1 2026
Trulieve Cannabis has published its Q1 2026 quarterly earnings report on May 7, 2026.